Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trialBradley J. Monk, Jyoti Mayadev, Sewanti Limaye et al.|The Lancet Oncology|2023Cited by 214
A dosimetric analysis of intensity-modulated radiation therapy with bone marrow sparing for cervical cancer.Naoya Murakami, Jun Itami, Hiroyuki Okamoto et al.|PubMed|2014Cited by 17
O001/#504 Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trialBradley J. Monk, Jyoti Mayadev, Takafumi Toita et al.|International Journal of Gynecological Cancer|2022Cited by 15
Japanese Structure Survey of High-precision Radiotherapy in 2012 Based on Institutional Questionnaire about the Patterns of CareNatsuo Tomita, Katsumasa Nakamura, Takeshi Kodaira et al.|Japanese Journal of Clinical Oncology|2014Cited by 13
Revision of guideline for structure of radiation oncology by the patterns of care studyTeruki Teshima, Toshihiko Inoue, Hideo Tatsuzaki et al.|Unknown|2006Cited by 0